Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Therapeutics, Inc., ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (RAPT Therapeutics, Inc.), Common Stock Warrant Agreement (RAPT Therapeutics, Inc.), Warrant Agreement (RAPT Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Poseida Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Poseida Therapeutics, Inc.), Preferred Stock Warrant Agreement (Poseida Therapeutics, Inc.), Warrant Agreement (Poseida Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Therapeutics, Inc., ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (RAPT Therapeutics, Inc.), Common Stock Warrant Agreement (RAPT Therapeutics, Inc.), Warrant Agreement (RAPT Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Cara Therapeutics, Inc., Inc. 4 ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Cara Therapeutics, Inc.), Warrant Agreement (Cara Therapeutics, Inc.), Warrant Agreement (Cara Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Protagonist Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇., ▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Protagonist Therapeutics, Inc), Common Stock Warrant Agreement (Protagonist Therapeutics, Inc), Debt Securities Warrant Agreement (Protagonist Therapeutics, Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Travere Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Warrant Agreement (Travere Therapeutics, Inc.), Preferred Stock Warrant Agreement (Travere Therapeutics, Inc.), Warrant Agreement (Travere Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Therapeutics, Prevail Therapeutics Inc., ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Warrant Agreement (Prevail Therapeutics Inc.), Preferred Stock Warrant Agreement (Prevail Therapeutics Inc.), Warrant Agreement (Prevail Therapeutics Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Poseida Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Poseida Therapeutics, Inc.), Preferred Stock Warrant Agreement (Poseida Therapeutics, Inc.), Warrant Agreement (Poseida Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT ▇▇▇▇ Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Vera Therapeutics, Inc.), Warrant Agreement (Vera Therapeutics, Inc.), Warrant Agreement (Vera Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Outlook Therapeutics, Inc., ▇4▇▇ ▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (Outlook Therapeutics, Inc.), Common Stock Warrant Agreement (Outlook Therapeutics, Inc.), Debt Securities Warrant Agreement (Outlook Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Therapeutics, Inc., ▇Structure Therapeutics Inc. 6▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇, ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Shares Warrant Agreement (Structure Therapeutics Inc.), Ordinary Shares Warrant Agreement (Structure Therapeutics Inc.), Debt Securities Warrant Agreement (Structure Therapeutics Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT ImmunoCellular Therapeutics, Inc.Ltd., ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Preferred Stock Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Warrant Agreement (ImmunoCellular Therapeutics, Ltd.), Warrant Agreement (ImmunoCellular Therapeutics, Ltd.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Travere Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Travere Therapeutics, Inc.), Warrant Agreement (Travere Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT ▇▇▇▇ Therapeutics, Inc., Inc. ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Vera Therapeutics, Inc.), Warrant Agreement (Vera Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Design Therapeutics, Inc., Inc. ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Warrant Agreement (Design Therapeutics, Inc.), Warrant Agreement (Design Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Turning Point Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Turning Point Therapeutics, Inc.), Preferred Stock Warrant Agreement (Turning Point Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Marker Therapeutics, Inc., 3▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇, ▇▇▇▇▇, Attention: [●] Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Marker Therapeutics, Inc.), Common Stock Warrant Agreement (Marker Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Protagonist Therapeutics, Inc., Inc. ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Protagonist Therapeutics, Inc), Common Stock Warrant Agreement (Protagonist Therapeutics, Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Cara Therapeutics, Inc., Inc. ▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Preferred Stock Warrant Agreement (Cara Therapeutics, Inc.), Warrant Agreement (Cara Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Travere Therapeutics, Inc., Inc. ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Preferred Stock Warrant Agreement (Travere Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Gain Therapeutics, Inc., Inc. ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Common Stock Warrant Agreement (Gain Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Gain Therapeutics, Inc., Inc. 4▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Preferred Stock Warrant Agreement (Gain Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT ▇▇▇▇ Therapeutics, Inc., ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇ Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT TherapeuticsActinium pharmaceuticals, Inc., ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Preferred Stock Warrant Agreement (Actinium Pharmaceuticals, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to RAPT Gain Therapeutics, Inc., 4▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇, ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Debt Securities Warrant Agreement (Gain Therapeutics, Inc.)